Industry
Healthcare & Life Sciences
Computation and automation around clinical and research workflows — at development stage, and described that way.
Our healthcare work is development-stage research. Nothing described here is a medical device, none of it holds regulatory clearance, and none of it is for clinical use or diagnosis.
Problems we address
- Imaging and reporting backlogs growing faster than radiology headcount
- Clinicians spending more of the day on documentation than on patients
- Patient and operational data spread across systems that were never meant to talk to each other
- Research pipelines where compute is the bottleneck, not the hypothesis
How we approach it
AI & Automation
Workflow automation and decision support with a clinician in the loop, scoped so the failure mode is visible before it matters.
Quantum & Advanced Computing
Genomic and molecular workloads assessed for where advanced methods are worth testing — and where they are not.
Product Engineering
Integration across clinical and administrative systems, built to survive an audit.
Related research
Maturity labels are not decoration. Most of this is at concept stage.
Optimized Cancer Treatment
Personalised treatment planning, scheduling and dose/therapy optimisation concepts.
Personalized Medicine
Multi-omics, clinical data and patient stratification for personalised decisions.
Rapid Genomic Sequencing
Sequencing itself is fast and cheap now; interpretation is not. Alignment and variant calling dominate the timeline, but deciding which of thousands of variants actually matters is a knowledge problem more than a compute one. Before optimising anything we would want an end-to-end timing breakdown on a real pipeline — speeding up a stage that is not the bottleneck is a common and expensive mistake.
Advanced Medical Imaging
Image reconstruction, denoising, classification and diagnostic assistance.
Quantum-Powered Cancer Detection AI by QuZone
Published on the legacy site as a case study, with sensitivity figures, multi-cancer coverage and language implying regulatory readiness. All of it was withdrawn: no study, named partner or clearance supported any of it. What remains is an early-stage research programme in multimodal diagnostic support — not a medical device, and not for diagnostic use.